Pharma · Public company · Jersey City, NJ, US
Organon & Co.
Ticker OGN · SEC CIK 0001821825
Track this companyFree. Adds Organon & Co. to your Dealase workspace and tells you when its record changes.
Clinical trials192 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline9
- NOMAC-E2 COCPhase 3 · ContraceptionClinicalTrials.gov · fetched Nov 12, 2026
- Radiopaque Etonogestrel (ENG) ImplantPhase 3 · ContraceptionClinicalTrials.gov · fetched Nov 12, 2026
- TapinarofPhase 3 · Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- tapinarof cream, 1%Phase 3 · Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- Tapinarof cream, 1%Phase 3 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle CreamPhase 3 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle CreamPhase 3 · Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- OG-6219Phase 2 · EndometriosisClinicalTrials.gov · fetched Nov 12, 2026
- VTAMA® (tapinarof) Cream 1%PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials19
- A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic DermatitisPHASE3 · ACTIVE_NOT_RECRUITING · started Dec 29, 2025ClinicalTrials.gov NCT07265479 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar KeratodermaPHASE2 · ACTIVE_NOT_RECRUITING · started Oct 30, 2024ClinicalTrials.gov NCT06561321 · fetched Nov 12, 2026
- A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck RegionPHASE4 · COMPLETED · started Mar 13, 2023ClinicalTrials.gov NCT05789576 · fetched Nov 12, 2026
- A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque PsoriasisPHASE4 · COMPLETED · started Dec 27, 2022ClinicalTrials.gov NCT05680740 · fetched Nov 12, 2026
- A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related PainPHASE2 · COMPLETED · started Oct 25, 2022ClinicalTrials.gov NCT05560646 · fetched Nov 12, 2026
- Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral ContraceptivePHASE3 · TERMINATED · started Feb 17, 2022ClinicalTrials.gov NCT05264506 · fetched Nov 12, 2026
- Tapinarof for the Treatment of Plaque Psoriasis in Pediatric SubjectsPHASE3 · COMPLETED · started Dec 2, 2021ClinicalTrials.gov NCT05172726 · fetched Nov 12, 2026
- Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic DermatitisPHASE2 · COMPLETED · started Nov 15, 2021ClinicalTrials.gov NCT05186805 · fetched Nov 12, 2026
- Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic DermatitisPHASE3 · COMPLETED · started Oct 28, 2021ClinicalTrials.gov NCT05142774 · fetched Nov 12, 2026
- Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)PHASE3 · COMPLETED · started Sep 23, 2021ClinicalTrials.gov NCT05032859 · fetched Nov 12, 2026
- Tapinarof for the Treatment of Atopic Dermatitis in Children and AdultsPHASE3 · COMPLETED · started Sep 1, 2021ClinicalTrials.gov NCT05014568 · fetched Nov 12, 2026
- Perceptions of LARC Among AYA With Chronic IllnessCOMPLETED · started Apr 16, 2021ClinicalTrials.gov NCT05000489 · fetched Nov 12, 2026
- Evaluating the Mobile Clinic Model as a Means of Increasing Access to Reproductive and Sexual HealthUNKNOWN · started Jan 1, 2021ClinicalTrials.gov NCT05013710 · fetched Nov 12, 2026
- A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)PHASE3 · COMPLETED · started Nov 19, 2020ClinicalTrials.gov NCT04626596 · fetched Nov 12, 2026
- Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)PHASE3 · COMPLETED · started Aug 13, 2019ClinicalTrials.gov NCT04053387 · fetched Nov 12, 2026
- Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque PsoriasisPHASE2 · COMPLETED · started Jul 23, 2019ClinicalTrials.gov NCT04042103 · fetched Nov 12, 2026
- Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)PHASE3 · COMPLETED · started Jun 6, 2019ClinicalTrials.gov NCT03983980 · fetched Nov 12, 2026
- Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)PHASE3 · COMPLETED · started May 21, 2019ClinicalTrials.gov NCT03956355 · fetched Nov 12, 2026
- Pilot Study of ORG 25935 Modulation of Ketamine-induced Behavioral and Cognitive Effects in Healthy Male SubjectsPHASE1 · COMPLETED · started Jan 22, 2008ClinicalTrials.gov NCT00700076 · fetched Nov 12, 2026
SEC filings12
- 8-K · FORM 8-KSEC EDGAR · filed Oct 30, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Oct 30, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 31, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Jul 31, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 23, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 17, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 11, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 4, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Apr 30, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 27, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Feb 24, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Feb 20, 2026 · fetched Nov 12, 2026